H. Kruse

发表

PATHOGENESIS AND NATURAL COURSE OF PRIMARY OSTEOPOROSIS

H. Kruse, F. Kuhlencordt, 1980, The Lancet.

Solving Flavor Problems by Sensory Methods

H. Kruse, M. Rothe, 1999 .

Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis

M. Amling, P. Fardellone, H. Kruse, 2009, Drugs & aging.

The identification of 1,3-oxazolidine-2-thiones and 1,3-thiazolidine-2-thiones from the reaction of glucose with benzyl isothiocyanate.

M. Heydenreich, W. Engst, U. Schilde, 2005, Carbohydrate research.

Generalized Bone Diseases

P. Dietsch, H. Kruse, F. Kuhlencordt, 1987, Springer Berlin Heidelberg.

Comparative biokinetics and metabolism of pure monomeric, dimeric, and polymeric flavan-3-ols: a randomized cross-over study in humans.

S. Kulling, A. Bub, P. Winterhalter, 2015, Molecular nutrition & food research.

Proceedings: Bone mineral determinations on long-term diabetics.

H. Kruse, F. Kuhlencordt, J. Ringe, 1976, AJR. American journal of roentgenology.

Effects of fusarium infection on the phenolics in emmer and naked barley.

E. Pawelzik, K. Eggert, H. Kruse, 2010, Journal of agricultural and food chemistry.

Calcium Metabolism, Bone and Metabolic Bone Diseases

H. Kruse, F. Kuhlencordt, 1975, Springer Berlin Heidelberg.

Effect of dietary genistein on Phase II and antioxidant enzymes in rat liver.

G. Rimbach, H. Wiegand, S. Kulling, 2009, Cancer genomics & proteomics.

Characterization and modeling of the interactions between coffee storage proteins and phenolic compounds.

H. Kruse, T. Homann, H. Rawel, 2012, Journal of agricultural and food chemistry.

Milk whey protein modification by coffee-specific phenolics: effect on structural and functional properties.

H. Kruse, T. Homann, H. Rawel, 2013, Journal of agricultural and food chemistry.

Effects of inulin on faecal bifidobacteria in human subjects

M. Blaut, H. Kruse, B. Kleessen, 1999, British Journal of Nutrition.

Effect of vitamin D3 treatment on bone density in neurofibromatosis 1 patients: a retrospective clinical study.

V. Mautner, J. Friedman, C. Schnabel, 2013, Joint, bone, spine : revue du rhumatisme.

Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.

M. Dougados, J. Reginster, C. Roux, 1995, Arthritis and rheumatism.

On an Attempt to Treat Primary and Secondary Osteoporosis with Human Growth Hormone*

H. Kruse, F. Kuhlencordt, F Kuhlencordt, 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The impact of fewer hip fractures with risedronate versus alendronate in the first year of treatment: modeled German cost-effectiveness analysis.

H. Kruse, D. Grima, M. Thompson, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency*

D. Gold, G. Iolascon, H. Kruse, 2006, Current medical research and opinion.

Structural changes induced in bovine serum albumin by covalent attachment of chlorogenic acid

S. Rohn, H. Kruse, H. Rawel, 2002 .

Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis

D. Felsenberg, J. Pfeilschifter, H. Kruse, 2004, Current medical research and opinion.

Pharmacoeconomic analysis of osteoporosis treatment with risedronate.

D. Felsenberg, A. Oestreich, E. Huppertz, 2003, International journal of clinical pharmacology research.

Correlation of clinical, densitometric, and histomorphometric data in osteoporosis

H. Kruse, F. Kuhlencordt, J. Ringe, 1975, Calcified Tissue Research.

[Estimation of bone mineral content by means of 125I photon absorption measurements in normals (author's transl)].

H. Kruse, F. Kuhlencordt, J. Ringe, 1974, Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].

H. Kruse, F. Kuhlencordt, J. Ringe, 2008, Deutsche medizinische Wochenschrift.

Efforts toward combined analgesic/antidepressants: synthesis and evaluation of (3-aryl-2,3-dihydrobenzofuran-3-yl)alkanamines.

H. Kruse, J. Wilker, C. Diamond, 1985, Journal of pharmaceutical sciences.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

A. Oestreich, E. Huppertz, H. Kruse, 2004, International journal of clinical pharmacology research.

[The prevention and therapy of steroid-induced osteoporosis].

H. Kruse, 1999, Deutsche medizinische Wochenschrift.

Severe Cystic Bone Lesions: Skeletal Manifestation of Mastocytosis or Special Kind of Primary Osteoporosis?

G. Delling, H. Kruse, F. Kuhlencordt, 1987 .